Literature DB >> 25710748

Surgical management of osteoradionecrosis of the jaws.

Tianguo Dai1, Zhuowei Tian, Zhonghe Wang, Weiliu Qiu, Zhiyuan Zhang, Yue He.   

Abstract

OBJECTIVE: The objective of this study is to evaluate our 10-year clinical experience in surgical management of patients with osteoradionecrosis (ORN) unresolved with conservative nonoperative treatment. PATIENTS AND METHODS: The medical records of 120 patients who had been surgically treated for ORN during a 10-year period (January 2003 to January 2013) were retrospectively reviewed.
RESULTS: The most predilection ORN site was mandible (82.5%), followed by the maxilla (11.7%). ORN developed within initial 12 months in 39.2% and within the first 3 years in 68.3%. The median radiation dose was 68.1 Gy (range, 35-148 Gy), but 51 patients (42.5%) experienced ORN even though radiation doses were controlled under 60 Gy. Surgical trauma, as we believed, was the most important factor leading to this result. Among all the patients, 12 (10.0%) patients were found ineligible for operative treatment due to comorbid systematic diseases whereas none healed or improved. In terms of surgical management of the rest of the 108 patients, 90 (75.0%) patients underwent radical resection (4 patients unhealed), and 18 (15.0%) patients underwent mild surgical procedures such as sequestrectomy or debridement (1 patient unhealed). Of the 90 radical resection patients, 58 patients underwent radical resections and immediate microvascular flap reconstruction (19 bone flaps and 39 soft flaps), and 32 patients only experience radical resection (5 patients received second-stage reconstruction). According to follow-up information, 55 patients were free of disease.
CONCLUSION: Though priority should be given to surgical treatment for the patient whose ORN does not respond to conservative nonoperative treatment, we may as well take into account more individualized regimens based on ORN severity. A hard lesson learned from our article is that the oral maxillofacial surgeon should minimize the trauma for jaws as possible as he can, especially to patients who need to receive postoperative radiotherapy.

Entities:  

Mesh:

Year:  2015        PMID: 25710748     DOI: 10.1097/SCS.0000000000001445

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Intensity-modulated radiotherapy does not induce volumetric changes of the Bichat fat pad in nasopharyngeal cancer.

Authors:  Alberto Cacciola; Sara Lillo; Silvana Parisi; Consuelo Tamburella; Anna Brogna; Gianluca Ferini; Alfredo Blandino; Fabio Minutoli; Stefano Pergolizzi
Journal:  Strahlenther Onkol       Date:  2022-07-14       Impact factor: 4.033

2.  Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity.

Authors:  Kristin Lang; Melissa Baur; Sati Akbaba; Thomas Held; Steffen Kargus; Nina Bougatf; Denise Bernhardt; Kolja Freier; Peter K Plinkert; Stefan Rieken; Jürgen Debus; Sebastian Adeberg
Journal:  Cancers (Basel)       Date:  2018-12-04       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.